Pathogenesis of Clostridium difficile infection.

Clostridium difficile produces two major toxins referred to as toxins A and B. These are thought to be primarily responsible for the virulence of the bacterium and the major contributors to the pathogenesis of antibiotic-associated gastrointestinal disease. The molecular organization and control of expression of toxins A and B is now starting to be understood, and the cellular mechanism of action of both toxins, glucosylation of Rho family proteins, has been discovered. Other factors, such as production of proteolytic and hydrolytic enzymes, expression of fimbriae and flagella, chemotaxis and adhesion to gut receptors, and production of capsule, may all play a part in pathogenesis by facilitating colonization or by directly contributing to tissue damage, or both. Differential expression between strains of various combinations of these colonization and virulence factors may explain the apparent variability in virulence of C. difficile strains.

[1]  J. Brazier The epidemiology and typing of Clostridium difficile. , 1998, The Journal of antimicrobial chemotherapy.

[2]  M. O'brien,et al.  Differential effects of Clostridium difficile toxins A and B on rabbit ileum. , 1987, Gastroenterology.

[3]  E. Rubin,et al.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain , 1988, Infection and immunity.

[4]  P. Millard,et al.  Clostridium difficile diarrhoea: a highly infectious organism. , 1984, Age and ageing.

[5]  J. Bartlett,et al.  ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS IN CHILDREN , 1981, Pediatrics.

[6]  J. Bartlett Antibiotic associated diarrhea. , 2002, Delaware medical journal.

[7]  W. E. Golden,et al.  Pseudomembranous colitis. , 1996, The Journal of the Arkansas Medical Society.

[8]  S. Finegold,et al.  Clostridium difficile : its role in intestinal disease , 1988 .

[9]  S. Borriello,et al.  Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. , 1988, Journal of medical microbiology.

[10]  J. Johnson,et al.  The toxigenic element of Clostridium difficile strain VPI 10463. , 1995, Microbial pathogenesis.

[11]  S. Borriello,et al.  Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model. , 1990, Journal of medical microbiology.

[12]  J. Ketley,et al.  Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin. , 1987, Journal of medical microbiology.

[13]  A. Price,et al.  Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.

[14]  I. C. Hall,et al.  INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .

[15]  K. Watanabe,et al.  Effects of Clostridium difficile toxin A and toxin B on phospholipase D activation in human promyelocytic leukemic HL60 cells , 1996, Infection and immunity.

[16]  C. Surawicz,et al.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.

[17]  K. Wilson,et al.  Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora , 1988, Infection and immunity.

[18]  M. Delmée,et al.  Virulence of ten serogroups of Clostridium difficile in hamsters. , 1990, Journal of medical microbiology.

[19]  G. Corthier,et al.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.

[20]  A. Price,et al.  Epidemiology of experimental enterocecitis due to Clostridium difficile. , 1980, The Journal of infectious diseases.

[21]  T. Wilkins,et al.  Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.

[22]  I. Hill,et al.  Epidemiology of Clostridium difficile in infants. , 1982, The Journal of infectious diseases.

[23]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[24]  C. von Eichel-Streiber,et al.  Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. , 1997, FEMS microbiology letters.

[25]  K. Aktories,et al.  The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. , 1995, The Journal of clinical investigation.

[26]  J. Ketley,et al.  Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. , 1986, Gut.

[27]  P. Sipponen,et al.  Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. , 1981, Scandinavian journal of gastroenterology.

[28]  S. Borriello,et al.  Virulence factors of Clostridium difficile. , 1990, Reviews of infectious diseases.

[29]  J. Ketley,et al.  The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. , 1987, Journal of Medical Microbiology.

[30]  S. Borriello,et al.  Cell surface properties of Clostridium difficile: haemagglutination, relative hydrophobicity and charge. , 1996, Journal of medical microbiology.

[31]  S. Donta,et al.  Clostridium difficile toxin A in infants. , 1983, The Journal of infectious diseases.

[32]  T. Gray,et al.  Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. , 1996, Gut.

[33]  S. Borriello,et al.  Evaluation of the predictive capability of an in-vitro model of colonisation resistance to Clostridium difficile infection , 1988 .

[34]  T. Wilkins,et al.  Biological activities of toxins A and B of Clostridium difficile , 1982, Infection and immunity.

[35]  S. Borriello,et al.  Specific binding of nucleotides and NAD+ to Clostridium difficile toxin A , 1992, FEBS letters.

[36]  S. Borriello,et al.  Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters , 1990, Antimicrobial Agents and Chemotherapy.

[37]  M. Wilm,et al.  The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.

[38]  R. Guerrant,et al.  Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro , 1988, Infection and immunity.

[39]  S. Borriello,et al.  Detection of capsule in strains of Clostridium difficile of varying virulence and toxigenicity. , 1990, Microbial pathogenesis.

[40]  R Sedivy,et al.  Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. , 1995, The Journal of clinical investigation.

[41]  Y. Banno,et al.  Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. , 1984, Reviews of infectious diseases.

[42]  B. Werneburg,et al.  Clostridium difficile toxin B: characterization and sequence of three peptides. , 1989, Journal of chromatography.

[43]  T. Wilkins,et al.  Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y , 1991, Infection and immunity.

[44]  A. Price,et al.  Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. , 1987, Journal of medical microbiology.

[45]  K. Saum,et al.  Effects of Clostridium difficile toxins given intragastrically to animals , 1985, Infection and immunity.

[46]  -. Steffen,et al.  Hydrolytic enzymes of anaerobic bacteria isolated from human infections , 1981, Journal of clinical microbiology.

[47]  S. Borriello,et al.  Antibiotic and pseudomembranous colitis. , 1981, The Journal of antimicrobial chemotherapy.

[48]  C L Oakley,et al.  Clostridium difficile: isolation and characteristics. , 1976, Journal of medical microbiology.

[49]  A. Servin,et al.  Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte‐like Caco‐2 and mucus‐secreting HT29 cells in culture , 1993, Molecular microbiology.

[50]  S. Borriello,et al.  Evaluation of the proposed interaction of nucleic acid with Clostridium difficile toxins A and B and the effects of nucleases on cytotoxicity. , 1991, FEMS Microbiology Letters.

[51]  P. Bourlioux,et al.  Cloning of a genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus , 1994, Infection and immunity.

[52]  S. Borriello,et al.  Detection of fimbriae amongst strains of Clostridium difficile , 1988 .

[53]  R. H. Schloemer,et al.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes , 1987, Infection and immunity.

[54]  J. Bartlett,et al.  Myoelectric effects of Clostridium difficile: motility-altering factors distinct from its cytotoxin and enterotoxin in rabbits. , 1982, Gastroenterology.

[55]  M. Popoff,et al.  Survey of neuraminidase production by Clostridium butyricum, Clostridium beijerinckii, and Clostridium difficile strains from clinical and nonclinical sources , 1985, Journal of clinical microbiology.

[56]  I. Florin,et al.  Polyphosphate-mediated protection from cellular intoxication with Clostridium difficile toxin B. , 1984, Biochimica et biophysica acta.

[57]  S. Borriello,et al.  An in-vitro model of colonisation resistance to Clostridium difficile infection. , 1986, Journal of medical microbiology.

[58]  T. Wilkins,et al.  Positive regulation of Clostridium difficile toxins , 1997, Infection and immunity.

[59]  S. Donta,et al.  Neonatal antibiotic-associated colitis. , 1981, American journal of diseases of children.

[60]  L. A. Barroso,et al.  Nucleotide sequence of Clostridium difficile toxin B gene , 1990, Nucleic Acids Res..

[61]  S. Borriello,et al.  Nonspecific Binding of Clostridium difficile Toxin A to Murine Immunoglobulins Occurs via the Fab Component , 1998, Infection and Immunity.

[62]  J. Bartlett Antibiotic-associated pseudomembranous colitis. , 1979, Hospital practice.

[63]  M. Giuliano,et al.  Production of an enterotoxin different from toxin A by Clostridium difficile , 1988 .

[64]  J. Johnson,et al.  Transcriptional analysis of the toxigenic element of Clostridium difficile. , 1997, Microbial pathogenesis.

[65]  J. Johnson,et al.  Molecular characterization of the Clostridium difficile toxin A gene , 1990, Infection and immunity.